Seeking Alpha

figaro75

figaro75
Send Message
View as an RSS Feed
View figaro75's Comments BY TICKER:
Latest  |  Highest rated
  • Update: Response Genetics Announces Leadership Extension - Impacts To My Thesis [View article]
    I'm totally disappointed in this stock performance. Personally I'm surprised that Bologna thinks he can squeeze yet another $1.06M per year out of the company.
    Oct 1, 2014. 01:10 PM | 1 Like Like |Link to Comment
  • Response Genetics' (RGDX) CEO Thomas Bologna on Q2 2014 Results - Earnings Call Transcript [View article]
    Hmmm, Nobody showing up for Q&A... A real indication of how poor the performance is!
    What a sad joke!
    Aug 14, 2014. 04:44 PM | Likes Like |Link to Comment
  • Response Genetics Q2 revenues up 24% [View news story]
    Nice going guys! And here I thought you actually had good management! What garbage!
    Aug 14, 2014. 12:37 PM | Likes Like |Link to Comment
  • REM: Exposure To mREITs Without Having To Choose Just One [View article]
    Thanx for the reply (& article) and I generally agree. Yet.. REIT Preferreds appear to be safest imoho.
    M
    Jul 24, 2014. 02:30 AM | Likes Like |Link to Comment
  • REM: Exposure To mREITs Without Having To Choose Just One [View article]
    I personally like REM however the strong indication that we are gonna have rate increases next year indicates caution, It will be very possible that the 10-13% div offered would be very easily off-set by a corresponding drop in share price and then of course a reduction in it's dividend.
    I have been into preferreds, buying them when they were out of favor a few years ago. Unfortunately I sold them for the significant profits and now don't have that fat dividends. As long as one does not buy them above par (and making sure they are cumulative) delivers a safer and more guaranteed return.
    Jul 14, 2014. 06:16 PM | Likes Like |Link to Comment
  • Synergy Pharmaceuticals: An Interesting Investment Ahead Of Multiple Catalysts [View article]
    Thanks for the article. Yes, I agree and am invested accordingly. I would like to have seen your article give more dates as to when the phase 2b, and 3 would be finished as I am suspecting one might have rather immediate results.
    How is their relationship with the FDA?
    Jun 22, 2014. 04:04 AM | Likes Like |Link to Comment
  • AcelRx borrows second tranche of $10M from Hercules [View news story]
    Yea, I support another 10M! They are getting ready to hit the ground running and this is one of the instruments that will get them burning rubber!
    Go ACRX!
    Jun 16, 2014. 05:39 PM | 1 Like Like |Link to Comment
  • Response Genetics' (RGDX) CEO Thomas Bologna on Q1 2014 Results - Earnings Call Transcript [View article]
    I believe they did. Nobody there had any... Which is too bad.
    May 11, 2014. 07:28 PM | Likes Like |Link to Comment
  • Response Genetics' CEO Discusses Q4 2013 Results - Earnings Call Transcript [View article]
    I'm very interested to see just what they have up their sleeve!
    Mar 22, 2014. 02:13 PM | Likes Like |Link to Comment
  • Senesco: Near-Term Catalyst Could Double Shareprice [View article]
    Thanks for the article. Do you have a burn rate?
    Dec 28, 2013. 12:46 PM | Likes Like |Link to Comment
  • Stellar Biotechnologies: Innovation, Experience, And Upside [View article]

    Which major pharmas?
    Which senior and/or partner positions at which companies?
    While you mentioned Teva and JNJ. Which positions? Which companies did the CFO work for? Article seems light of specifics. How much of their revenue is attributable to sales to those companies? Even Yahoo doesn't indicate how many employees there are and they are not that forthcoming on their website either. While they may have interesting possibilities there are a lot of specifics lacking from many sources. I am cautious about a company which stock was selling for 16 cents earlier this year. And I think without more hard numbers and contractual relations with these large companies One should be most cautious. That's not saying there isn't something there. Just not conclusive by any means.
    Nov 30, 2013. 03:53 AM | 1 Like Like |Link to Comment
  • AcelRx: Huge Potential With Limited Risk [View article]
    Good summation. Please consider English a bit: "AcelRx is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain." It's not breakthrough pain, it's breakthrough treatment. There are still some of us who still care about clarity in sentence structure to disseminate our thoughts.
    And where are the Baker Bros on ACRX?
    Nov 28, 2013. 05:17 PM | Likes Like |Link to Comment
  • Zeltiq Aesthetics And Solta Medical Are Likely In Play [View article]
    I'm bringing popcorn for this show.
    Nov 14, 2013. 03:35 PM | Likes Like |Link to Comment
  • Little-Known Cynapsus Underway To Solve Crucial Problem For Parkinson's Sufferers [View article]
    1x10 r stock split in March '13 and only in phase 1... Doesn't speak well financing... or management possibly?
    Oct 3, 2013. 03:32 AM | Likes Like |Link to Comment
  • AcelRx Pharmaceuticals To Submit NDA By End Of September, May Be Acquired Soon [View article]
    Great Article. Compelling as usual from you, Scott, Thanks. I appreciate and respect your detailed and well researched efforts. Now If we can get SLTM sold, I will definitely get a chunk of ACRX :)
    Sep 20, 2013. 08:35 AM | Likes Like |Link to Comment
COMMENTS STATS
55 Comments
60 Likes